secwatch.observer — SEC 8-K summary
======================================

Issuer:     P3 Health Partners Inc. (PIII)
CIK:        0001832511
Form:       8-K
Filed at:   2024-05-09T23:59:59+00:00
Accession:  0001628280-24-022303
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

P3 Health Partners appoints Dr. Aric Coffman as CEO, replacing Dr. Sherif Abdou effective May 8, 2024
--------------------------------------------------------------------------------

- Dr. Coffman receives $750K base salary, 75% target bonus, and equity awards covering 16.5M shares (12.1M options, 4.4M RSUs).
- Outgoing CEO Dr. Abdou becomes Vice Chair of Board and Senior Advisor under consulting agreement for $400K fee through April 2025.
- Board adopts 2024 Employment Inducement Incentive Award Plan reserving 16.5M shares for inducement grants.
- Dr. Coffman previously CEO of Honest Medical Group; held leadership roles at DaVita Medical Group and Optum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832511/000162828024022303/0001628280-24-022303-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832511/000162828024022303/piii-20240507.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-022303

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer